The factors that affect the results of the response to rituximab treatment in ITP patients

The factors that affect the results of the response to rituximab treatment in ITP patients

Bibliographic Details
Main Authors:	O. Beyler, A. Gunes, G. Korkmaz Akat, F. Ceran, S. Dagdas, G. Ozet
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137920301784

Similar Items

PB2449: EFFECT OF MOBILIZATION METHODS ON CD34+ AND TOTAL NUCLEATED CELL COUNT AND THEIR RELATION WITH ENGRAFTMENT IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Ozlem Beyler, et al.
Published: (2023-08-01)

Rituximab resistance in ITP and beyond
by: Zhengrui Xiao, et al.
Published: (2023-07-01)

P1343: TRANSPLANT OUTCOMES OF LYMPHOMA PATIENTS UNDERGOING STEM CELL MOBILIZATION WITH PLERIXAFOR
by: A. K. Gunes, et al.
Published: (2022-06-01)

Response to rituximab in children and adults with immune thrombocytopenia (ITP)
by: Emily M. Harris, et al.
Published: (2021-08-01)

Investigating factors affecting the response to treatment in patients with ITP
by: Seyed Kamal Eshagh Hossaini, et al.
Published: (2022-12-01)

A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow cytometry
by: Zehra Narli Ozdemir, et al.
Published: (2023-04-01)

The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients
by: Funda Ceran, et al.
Published: (2017-08-01)

RITUXIMAB VERSUS SPLENECTOMY IN CHRONIC PRIMARY ITP: EXPERIENCE OF A SINGLE HEMATOLOGY CLINIC
by: Rawanda Shamoon, et al.
Published: (2024-02-01)

More about the combination of rituximab, cyclosporine and dexamethasone in the treatment of chronic ITP. A useful option on an environment with limited resources
by: Ahmad F. Thabet, et al.
Published: (2020-08-01)

NEXT GENERATION SEQUENCING PRACTICES IN HEMATOLOGY: A RECENT EXPERIENCE OF A SINGLE CENTER
by: Muruvvet Seda AYDIN, et al.
Published: (2021-11-01)

The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
by: Mesude Falay, et al.
Published: (2018-05-01)

PB2619: THE IMPACT OF ITP-DIRECTED TREATMENT ON FATIGUE AMONG CHILDREN AND ADOLESCENTS WITH CHRONIC ITP: DATA FROM THE ITP NATURAL HISTORY STUDY REGISTRY
by: Jennifer Diraimo, et al.
Published: (2023-08-01)

Evaluation of risk factors for thrombophilia in patients with cerebral venous thrombosis
by: Osman Yokuş, et al.
Published: (2010-09-01)

Evaluation of risk factors for thrombophilia in patients with cerebral venous thrombosis
by: Osman Yokuş, et al.
Published: (2010-10-01)

Evaluation of 143 Cases of Immune Thrombocytopenic Purpura With Regards to Clinical Course and Response to Treatment
by: Murat Albayrak, et al.
Published: (2010-12-01)

THE ACUTE LYMPHOBLASTIC LEUKEMIA OF DOWN SYNDROME
by: Cemile SELIMOGLU, et al.
Published: (2022-10-01)

Evaluation of Pediatric Immune Thrombocytopenia (ITP) Cases and Risk Factors for Chronic ITP - Single Center Experience
by: Osman Demir, et al.
Published: (2023-08-01)

ITP following vaccination
by: Paula David, et al.
Published: (2020-10-01)

ITP Project Anthology
by: Aitken, S, et al.
Published: (1997)

Editorial: Immune thrombocytopenia (ITP)—diagnosis and treatment
by: Tomás José González-López
Published: (2024-03-01)

Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura (ITP)
by: D Boyers, et al.
Published: (2011-05-01)

The Outcome of Withholding Pharmacologic Treatment in Children with Acute ITP
by: Jalil I Alezzi, et al.
Published: (2019-10-01)

The Outcome of Withholding Pharmacologic Treatment in Children with Acute ITP
by: Jalil I Alezzi, et al.
Published: (2019-10-01)

08 Lessons from ITP: treatment of refractory thrombocytopenia
by: Sacha Zeerleder
Published: (2021-04-01)

OUTCOME OF SPLENECTOMY IN THE TREATMENT OF ITP – ONE CENTER EXPERIENCE
by: Weronika Lebowa, et al.
Published: (2021-11-01)

Primary Immune Thrombocytopenic Purpura (ITP) and ITP Associated with Systemic Lupus Erythematosus: A Review of Clinical Characteristics and Treatment Modalities
by: Krishna Prasad Bashyal, et al.
Published: (2024-01-01)

Lifting the fog over ITP
by: Philip Young-Ill Choi
Published: (2020-04-01)

Managing ITP and thrombocytopenia in pregnancy
by: Renee Eslick, et al.
Published: (2020-04-01)

ITP, Early Presentation of Thymoma
by: M Abbasi, et al.
Published: (2005-03-01)

ITP, Early Presentation of Thymoma
by: Kamran Alimoghaddam, et al.
Published: (2005-06-01)

P1590: THE IFI27/TFEB PATHWAY MEDIATES THE IMPAIRED AUTOPHAGIC DEGRADATION OF ITP BONE MARROW MACROPHAGES, RESULTING IN IMPAIRED MEGAKARYOCYTE MATURATION IN ITP
by: Jin Wu, et al.
Published: (2023-08-01)

A rare extramedullary involvement in myeloma: lung parenchyma and association with unfavorable chromosomal abnormalities
by: Özlem Şahin Balçık, et al.
Published: (2010-06-01)

A rare extramedullary involvement in myeloma: lung parenchyma and association with unfavorable chromosomal abnormalities
by: Özlem Şahin Balçık, et al.
Published: (2010-06-01)

Role of flow cytometry in multiple myeloma and the prognostic significance of CD87 (uPAR) expression
by: Murat Albayrak, et al.
Published: (2010-09-01)

Role of flow cytometry in multiple myeloma and the prognostic significance of CD87 (uPAR) expression
by: Murat Albayrak, et al.
Published: (2010-10-01)

PB2608: THE MANAGEMENT OF IMMUNE THROMBOCYTOPENIA (ITP) IN NORWAY IN THE REAL LIFE – ANALYSIS OF THE NOR-ITP REGISTRY
by: Ekaterina Ilicheva, et al.
Published: (2023-08-01)

Protocol for the study and treatment of primary immune thrombocytopenia: ITP-2018
by: Emilio Monteagudo, et al.
Published: (2019-08-01)

Raccoon eyes in immune thrombocytopenia (ITP)
by: Prakas Kumar Mandal, et al.
Published: (2014-01-01)

IDIOPATHIC THROMBOCYTOPENIC PURPURA (i.T.P.)
by: Sh. MOHAMEDI M ZAMANIANPOUR ML GHASEMI
Published: (1987-12-01)

IDIOPATHIC THROMBOCYTOPENIC PURPURA (i.T.P.)
by: Sh. MOHAMEDI M ZAMANIANPOUR ML GHASEMI
Published: (1987-06-01)